A possible case of maculopapular eruption associated with glecaprevir/pibrentasvir treatment for chronic hepatitis C virus infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A possible case of maculopapular eruption associated with glecaprevir/pibrentasvir treatment for chronic hepatitis C virus infection

Published:2021-03-31 Issue:4 Volume:4 Page:92-94
ISSN:2574-4593
Container-title:Journal of Cutaneous Immunology and Allergy
language:en
Short-container-title:J Cutan Immunol Allergy

Author:

Tomiyasu Hiroka¹,Nakajima Saeko¹^ORCID,Kaku Yo²,Hirata Masahiro³,Kataoka Tatsuki³,Nomura Takashi¹^ORCID,Kabashima Kenji¹⁴

Affiliation:

1. Department of Dermatology Kyoto University Graduate School of Medicine Kyoto Japan

2. Department of Dermatology Kagawa University Faculty of Medicine Takamatsu Japan

3. Department of Diagnostic Pathology Kyoto University Graduate School of Medicine Kyoto Japan

4. Singapore Immunology Network (SIgN) and Skin Research Institute of Singapore (SRIS) Agency for Science, Technology and Research (A*STAR) Singapore Singapore

Publisher

Wiley

Subject

Dermatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cia2.12166

Reference7 articles.

1. Treatment of Chronic Hepatitis C: Efficacy, Side Effects and Complications

2. A method for estimating the probability of adverse drug reactions

3. Safety and efficacy of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C in patients aged 65 years or older

4. Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

5. Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP